Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

• Enrico Maffini,
• Larry D. Anderson,
• Brenda M. Sandmaier,
• Damian J. Green,
• Barry E. Storer,
• Dietger Niederwieser,
• Richard T. Maziarz,
• David G. Maloney,
• Rainer Storb

Affiliations

Enrico Maffini

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA

Larry D. Anderson

UT Southwestern Medical Center, Dallas, TX, USA

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA;University of Washington, Department of Medicine, Seattle, WA, USA

Damian J. Green

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA;University of Washington, Department of Medicine, Seattle, WA, USA

Barry E. Storer

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA;University of Washington, School of Public Health, Seattle, WA, USA

Dietger Niederwieser

University Hospital of Leipzig, Germany

Richard T. Maziarz

Oregon Health & Science University, Portland, OR, USA

David G. Maloney

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA;University of Washington, Department of Medicine, Seattle, WA, USA

Rainer Storb

Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA;University of Washington, Department of Medicine, Seattle, WA, USA